Bifalgorithm post · öxford-Harrington RARE DISEASE CENTRE · Targeting Spinal and Bulbar Muscular Atrophy
Mutant Receptors
Mutant Receptors (öxford-Harrington RARE DISEASE CENTRE · Targeting Spinal and Bulbar Muscular Atrophy) — "Professor Carlo Rinaldi, 2024 Oxford-Harrington Rare…
Ideas in this flowchart
- Development of a therapy for spinal and bulbar muscular atrophy
- Professor Carlo Rinaldi is developing the therapy
- He is the 2024 Oxford-Harrington Rare Disease Scholar
- The therapy targets mutant androgen receptors
- The condition is spinal and bulbar muscular atrophy